Surgical Management of Trigeminal Neuralgia

Introduction

Indications for Surgery

• Failure of adequate medical therapy (carbamazepine 600-1200 mg/day or oxcarbazepine)
• Intolerable side effects of pharmacotherapy
• Medically unfit for long-term drug therapy
• Patient preference for a more definitive treatment
• Recurrence after remission on medical therapy

Surgical Options

1. Peripheral Procedures (Least Invasive)

• The simplest non-medical intervention
• Absolute alcohol (0.5-0.75 mL) is injected into the peripheral branch of the affected trigeminal division
• Infraorbital nerve (V2), supraorbital nerve (V1), or mental/inferior alveolar nerve (V3) are targeted
• Provides pain relief in a high proportion of patients
• Limitation: Relapse occurs in most patients within 6-18 months; procedure can be repeated 1-2 times before more proximal procedures are required
• Advantage: Low morbidity, temporary sensory loss, corneal sensation preserved
• Suitable for elderly or high-risk surgical patients

2. Percutaneous Procedures (Gasserian Ganglion / Trigeminal Rhizotomy)

a) Radiofrequency Thermocoagulation (RFT)

• A needle electrode is placed through the foramen ovale under fluoroscopic/CT guidance
• Controlled thermal lesions (60-90°C) selectively destroy small myelinated (A-delta) and unmyelinated (C) pain fibers while sparing large myelinated touch fibers
• Advantage: Can selectively target affected divisions; immediate pain relief
• Complications: Facial numbness (in up to 50%), keratitis/corneal anesthesia (if V1 targeted), masseter weakness, and rarely anesthesia dolorosa (painful numbness) (~1-5%)
• Good long-term outcomes: ~90% initial pain relief; recurrence rate ~25% at 5 years

b) Glycerol Rhizotomy (Chemical Rhizolysis)

• Percutaneous injection of anhydrous glycerol into the trigeminal cistern (Meckel's cave) through the foramen ovale
• Causes chemical destruction of nerve fibers
• Advantage: Technically simpler; lower rate of facial numbness compared to RFT
• Complications: Facial numbness (mild), aseptic meningitis (rare), herpes labialis reactivation
• Pain recurrence rate is higher than RFT

c) Percutaneous Balloon Compression (Meckel's Cave Compression)

• A balloon catheter is inflated in the trigeminal ganglion via the foramen ovale
• Mechanical compression damages the nerve selectively
• Advantage: Can be performed under general anesthesia; no patient cooperation required
• Complications: Transient bradycardia/hypotension (trigeminocardiac reflex), masseter weakness, facial numbness
• Useful when V1 involvement is present (lower risk of corneal anesthesia than RFT)

3. Major Surgical Procedures

a) Microvascular Decompression (MVD) - Jannetta's Procedure (GOLD STANDARD)

1. A small retromastoid (suboccipital) posterior fossa craniotomy is performed on the ipsilateral side
2. The cerebellopontine angle is accessed under the operating microscope
3. The cerebellum is gently retracted to expose CN V at its root entry zone in the pons
4. The offending vessel (most commonly the superior cerebellar artery; occasionally the anterior inferior cerebellar artery or superior petrosal vein) is identified and freed of all adhesions
5. A cushion of nonabsorbable material (Ivalon/Teflon felt) is interposed between the vessel and the nerve, permanently separating them
6. Wound closure is performed in layers

• Only procedure that addresses the underlying cause (neurovascular compression)
• Preserves normal trigeminal sensation - no facial numbness
• Highest long-term pain-free rates: ~70-80% at 10 years
• Pain recurrence rate is lowest of all surgical procedures

• Operative mortality: < 0.5%
• Facial numbness (mild, transient) in ~5%
• Hearing loss/CN VIII injury (~1%)
• Cerebellar injury, cerebrospinal fluid leak, meningitis (rare)
• General anesthetic risks (relevant for elderly)

b) Stereotactic Radiosurgery (SRS) - Gamma Knife / LINAC

• Gamma Knife: 201 convergent cobalt-60 gamma ray beams, delivers 70-90 Gy to target
• LINAC (Linear Accelerator): X-ray based; uses arc-rotation technique

• A stereotactic frame is applied to the skull under local anesthesia
• High-resolution MRI guidance identifies the trigeminal nerve target (root entry zone, 3-4 mm from pons)
• A single high-dose fraction is delivered in one session (no incision, no anesthesia)

• Non-invasive (no craniotomy)
• Can be performed in elderly, frail, or anticoagulated patients
• No anesthesia required

• Delayed effect - pain relief occurs over weeks to months (not immediate)
• Facial numbness in 30-50% of patients (higher rate than MVD)
• Pain recurrence rate ~40-50% at 5 years

c) Partial Sensory Rhizotomy (Open Sensory Root Section)

• Posterior fossa approach with microsurgical partial sectioning of the sensory root of CN V
• Reserved for cases where no vascular compression is found at surgery
• Results in predictable sensory loss in the affected division
• Risk of anesthesia dolorosa

Comparison of Surgical Procedures

Choosing the Right Procedure

1. Age and medical fitness - elderly/frail patients are better served by percutaneous or radiosurgical approaches
2. Presence of neurovascular compression on MRI - if confirmed, MVD is the procedure of choice
3. Division involved - V1 involvement increases risk of corneal complications with RFT; balloon compression is preferable
4. Patient preference - some patients prefer non-invasive approaches
5. Recurrence after prior surgery - repeat percutaneous procedures or SRS may be used for recurrence after MVD

Special Considerations

• Secondary trigeminal neuralgia (due to MS, tumor, or other structural lesion) requires treatment of the underlying cause; MVD is generally less effective
• Anesthesia dolorosa (constant burning pain with facial numbness) is a feared complication of destructive procedures and is difficult to treat
• Corneal reflex monitoring is essential when V1 is targeted percutaneously to avoid corneal anesthesia

Summary